Sector | Healthcare | Compare with Sector peers |
Industry | Pharmaceuticals & Drugs | Compare with Industry peers |
Website | http://www.aartidrugs.com | |
Market Cap | 4,596.75 Cr. | |
Enterprise Value(EV) | 5,183.92 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 19.60 | Trailing Twelve Months Ending 2023-12 |
Price-Earning Ratio (PE) | 25.51 | Trailing Twelve Months Ending 2023-12 |
Industry PE | 41.30 | Trailing Twelve Months Ending 2023-12 |
Book Value / Share | 135.55 | Trailing Twelve Months Ending 2023-12 |
Price to Book Value | 3.69 | Calculated using Price: 500.00 |
Dividend Yield | 0.20 | Period Ending 2023-03 |
No. of Shares Subscribed | 9.19 Cr. | 91,935,000 Shares |
FaceValue | 10 | |
About Aarti Drugs Ltd. | ||
Aarti Drugs (ADL), incorporated in 1984, is engaged in the business of manufacturing generic bulk actives, advanced intermediates and specialty chemicals. The company is part of $265 million Aarti Group of Industries. |
1 Day |
|
-0.35% |
1 Week |
|
+0.86% |
1 Month |
|
+9.53% |
3 Month |
|
-6.77% |
6 Month |
|
+3.05% |
1 Year |
|
+18.63% |
2 Year |
|
+1.57% |
5 Year |
|
+217.53% |
10 Year |
|
+1009.38% |
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 32.78 | 20.65 | 21.6 | 19.24 | 17.97 | 23.65 | 35.81 | 21.03 | 14.93 | |
Return on Capital Employed (%) | 23.93 | 17.95 | 18.14 | 17.31 | 17.01 | 21.39 | 34.52 | 20.75 | 15.49 | |
Return on Assets (%) | 10.13 | 6.53 | 7.13 | 6.38 | 6.31 | 9.33 | 16.78 | 10.32 | 7.19 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 308 | 357 | 400 | 455 | 543 | 652 | 913 | 1,036 | 1,192 | 1,209 | |
Non Curr. Liab. | 211 | 244 | 297 | 312 | 321 | 301 | 257 | 232 | 296 | 309 | |
Curr. Liab. | 483 | 501 | 494 | 622 | 591 | 623 | 595 | 940 | 933 | 833 | |
Minority Int. | 0 | 0 | 0 | 0 | |||||||
Equity & Liab. | 1,002 | 1,102 | 1,191 | 1,389 | 1,455 | 1,577 | 1,766 | 2,208 | 2,421 | 2,352 | |
Non Curr. Assets | 476 | 537 | 620 | 653 | 671 | 673 | 709 | 815 | 929 | 1,014 | |
Curr. Assets | 526 | 565 | 571 | 737 | 784 | 899 | 1,057 | 1,393 | 1,492 | 1,338 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 1,002 | 1,102 | 1,191 | 1,389 | 1,455 | 1,577 | 1,766 | 2,208 | 2,421 | 2,352 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
Net Sales | 1,097 | 1,140 | 1,195 | 1,244 | 1,561 | 1,806 | 2,155 | 2,489 | 2,716 | 2,651 | |
Other Income | 1 | 4 | 1 | 2 | 1 | 5 | 11 | 2 | 4 | ||
Total Income | 1,098 | 1,140 | 1,199 | 1,245 | 1,563 | 1,808 | 2,159 | 2,500 | 2,718 | 2,655 | |
Total Expenditure | -925 | -960 | -1,005 | -1,042 | -1,350 | -1,541 | -1,714 | -2,156 | -2,407 | -2,327 | |
PBIDT | 173 | 180 | 194 | 203 | 213 | 267 | 445 | 344 | 312 | 328 | |
Interest | -42 | -48 | -40 | -38 | -44 | -37 | -26 | -24 | -37 | -33 | |
Depreciation | -31 | -37 | -38 | -40 | -43 | -49 | -50 | -50 | -50 | -50 | |
Taxation | -22 | -27 | -34 | -42 | -41 | -44 | -89 | -65 | -58 | -64 | |
Exceptional Items | 4 | 4 | 0 | ||||||||
PAT | 77 | 69 | 82 | 82 | 90 | 141 | 280 | 205 | 166 | 180 | |
Minority Interest | 0 | 0 | 0 | 0 | |||||||
Share Associate | |||||||||||
Other Related Items | |||||||||||
Consolidated Net Profit | 77 | 69 | 82 | 82 | 90 | 141 | 280 | 205 | 166 | 180 | |
Adjusted EPS | 8 | 7 | 9 | 9 | 10 | 15 | 30 | 22 | 18 | 20 |
Particulars | 10 years | 2011-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 21 | 105 | 133 | 175 | 70 | 143 | 251 | 155 | 70 | 134 | |
Cash Fr. Inv. | -76 | -107 | -99 | -107 | -74 | -62 | -33 | -72 | -150 | -164 | |
Cash Fr. Finan. | 53 | 1 | -33 | -68 | 4 | -80 | -215 | -81 | 92 | 17 | |
Net Change | -3 | -1 | 1 | 0 | 0 | 1 | 2 | 2 | 13 | -13 | |
Cash & Cash Eqvt | 5 | 4 | 5 | 3 | 3 | 5 | 7 | 9 | 22 | 8 |
Tue, 23 Apr 2024
Updates Aarti Drugs Limited has informed the Exchange regarding 'US FDA inspection at Formulations (Oncology) manufacturing facility of our Subsidiary (Pinnacle Life Science Private Limited) at Baddi, Himachal Pradesh '. |
Fri, 05 Apr 2024
Loss of Share Certificates Aarti Drugs Limited has informed the Exchange about Loss of Share Certificates |
Fri, 05 Apr 2024
Loss/Duplicate-Share Certificate-XBRL AARTI DRUGS LIMITED has informed the Exchange about Loss of share certificates |
Wed, 24 Apr 2024 |
Making Higher Highs for 3 days |
Making Higher Highs for 2 Days |
High Increase in 1 Month |
High Increase in 5 Years |
MFI Above 80 |